NEW YORK (GenomeWeb News) — The Genome Institute of Singapore will use Illumina's BeadChip technology to analyze 3,000 samples, Illumina said today.
 
The Institute will work with an undisclosed pharmaceutical company as they use Illumina’s HumanRef-8 Expression. No other information was provided.
 
Illumina said the technology enables researchers to perform genome-wide expression profiles on eight samples on a single microarray.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.